Posts Tagged ‘cell therapy’

Outlook and Trends for Biotech Industry

Posted in Life Sciences on Wednesday, November 14th, 2018. No comments yet
Tags: , , , ,

What is the 2019 outlook for research & development in the biotech industry? Pharmaceutical Processing magazine explores this question in an article, Outlook 2019: Tech, Data, and Biotech Boom. Emerson’s Bob Lenich joined other suppliers to this industry to share his thoughts on some of the issues, challenges and developments expected to occur in the […]

Tracking Cell Therapy Chain of Identity

Posted in Life Sciences, Operations Management on Monday, November 5th, 2018. No comments yet
Tags: , , , ,

Cell therapy is when: …cellular material is injected into a patient;[1] this generally means intact, living cells. For example, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy. For manufacturers in the Life Sciences industry, making these therapies poses challenges since each batch is specific to […]

Identify and Resolve Cell Therapy Batch Manufacturing Exceptions

Posted in Life Sciences, Operations Management on Tuesday, February 20th, 2018. No comments yet
Tags: , , , ,

We conclude our series on improving cell therapy manufacturing with a closer look at the review by exception process. In the manufacturing process of cell therapeutics, product cycle times are extremely short and any exceptions occurring during the production process must be found and addressed quickly. Emerson’s Bob Schiros notes that manufacturing execution systems, such […]

Digital Transformation to Paperless Production

Posted in Life Sciences, Operations Management on Friday, February 2nd, 2018. No comments yet
Tags: , , , , ,

Manufacturing processes have long been paper-based with log entries, initialing, signoffs and other transactions to manually record. While automation systems have captured some of this manual recordkeeping, they have not been able to capture everything. In batch manufacturing processes that produce thousands of batches each year, maintaining paper records for each batch is a time-consuming, […]

Reducing Execution Errors in Cell Therapeutics Manufacturing

Posted in Life Sciences, Operations Management on Thursday, January 18th, 2018. No comments yet
Tags: , , , ,

In an earlier post, Managing the Chain of Identity in Cell Therapeutics Manufacturing, we highlighted how the manufacturing process of these cell therapies must be performed with absolute accuracy the first time since each batch is produced for a specific patient. It’s critical during the production process that any execution errors be identified and corrected […]